224 related articles for article (PubMed ID: 1301961)
1. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
2. [Serum soluble interleukin 2 receptor levels in patients with diffuse connective tissue diseases].
Sun HY; Liu WL; Xiu HZ
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):528-30. PubMed ID: 8269781
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
Raziuddin S; al-Janadi MA; al-Wabel AA
J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-2 receptor in systemic lupus erythematosus and rheumatoid arthritis.
Lee GL; Chen MY; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Feb; 21(1):16-22. PubMed ID: 3264781
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
6. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
8. Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus.
Itoh M; Goto Y; Ohta Y; Goto Y; Ohashi H
Clin Rheumatol; 1998; 17(1):26-30. PubMed ID: 9586675
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases.
Manoussakis MN; Papadopoulos GK; Drosos AA; Moutsopoulos HM
Clin Immunol Immunopathol; 1989 Mar; 50(3):321-32. PubMed ID: 2783895
[TBL] [Abstract][Full Text] [Related]
11. Study of interleukin-2 receptor in schistosomiasis mansoni and its analogous changes in collagen diseases and schistosomal arthropathy.
Khalil HM; el Missiry AG; Fahmy HM; Khalil NM; Nadia ; Sabry M; Abdel Atty HE; Tamara FA; Amer N; el Baz HG
J Egypt Soc Parasitol; 1995 Aug; 25(2):289-302. PubMed ID: 7665927
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
13. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
14. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus.
Daza L; Lavalle C; Duarte C; Huerta R; Moreno J
Lupus; 2003; 12(2):107-11. PubMed ID: 12630754
[TBL] [Abstract][Full Text] [Related]
16. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
[TBL] [Abstract][Full Text] [Related]
18. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
19. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis].
Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP
Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.
Carpenter AB; Eisenbeis CH; Carrabis S; Brown MC; Ip SH
J Clin Lab Anal; 1990; 4(2):130-4. PubMed ID: 2313471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
